These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3036804

  • 21. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect.
    Shisheva A, Shechter Y.
    Endocrinology; 1993 Oct; 133(4):1562-8. PubMed ID: 8404595
    [Abstract] [Full Text] [Related]

  • 22. Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide.
    Hayes GR, Lockwood DH.
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8115-9. PubMed ID: 3317401
    [Abstract] [Full Text] [Related]

  • 23. Insulin activates the appearance of insulin-like growth factor II receptors on the adipocyte cell surface.
    Oka Y, Mottola C, Oppenheimer CL, Czech MP.
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4028-32. PubMed ID: 6330732
    [Abstract] [Full Text] [Related]

  • 24. Differential dephosphorylation of the insulin receptor and its 160-kDa substrate (pp160) in rat adipocytes.
    Mooney RA, Bordwell KL.
    J Biol Chem; 1992 Jul 15; 267(20):14054-60. PubMed ID: 1321133
    [Abstract] [Full Text] [Related]

  • 25. Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes.
    Eriksson JW, Lönnroth P, Smith U.
    Diabetologia; 1992 Jun 15; 35(6):510-6. PubMed ID: 1319359
    [Abstract] [Full Text] [Related]

  • 26. Stimulation of 125I-transferrin binding and 59Fe uptake in rat adipocytes by vanadate: treatment time determines apparent tissue sensitivity.
    Tang S, Lu B, Fantus IG.
    Metabolism; 1998 Jun 15; 47(6):630-6. PubMed ID: 9627358
    [Abstract] [Full Text] [Related]

  • 27. Stimulatory effect of vanadate on 3',5'-cyclic guanosine monophosphate-inhibited low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads.
    Ueki H, Okuhama R, Sera M, Inoue T, Tominaga N, Morita T.
    Endocrinology; 1992 Jul 15; 131(1):441-6. PubMed ID: 1319324
    [Abstract] [Full Text] [Related]

  • 28. Combination of insulinomimetic agents H2O2 and vanadate enhances insulin receptor mediated tyrosine phosphorylation of IRS-1 leading to IRS-1 association with the phosphatidylinositol 3-kinase.
    Wilden PA, Broadway D.
    J Cell Biochem; 1995 Jul 15; 58(3):279-91. PubMed ID: 7593251
    [Abstract] [Full Text] [Related]

  • 29. Quantitative dissociation of glucose transport stimulation and insulin receptor tyrosine kinase activation in isolated adipocytes with a covalent insulin dimer (B29,B29'-suberoyl-insulin).
    Joost HG, Göke R, Schmitz-Salue C, Steinfelder HJ, Brandenburg D.
    Biochem Pharmacol; 1989 Jul 15; 38(14):2269-77. PubMed ID: 2546561
    [Abstract] [Full Text] [Related]

  • 30. Insulin-mimetic effect of trypsin on the insulin receptor tyrosine kinase in intact adipocytes.
    Leef JW, Larner J.
    J Biol Chem; 1987 Oct 25; 262(30):14837-42. PubMed ID: 2822700
    [Abstract] [Full Text] [Related]

  • 31. Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport.
    Sinha MK, Buchanan C, Leggett N, Martin L, Khazanie PG, Dimarchi R, Pories WJ, Caro JF.
    Diabetes; 1989 Oct 25; 38(10):1217-25. PubMed ID: 2551760
    [Abstract] [Full Text] [Related]

  • 32. Chromaffin cells express two types of insulin-like growth factor receptors.
    Danielsen A, Larsen E, Gammeltoft S.
    Brain Res; 1990 Jun 04; 518(1-2):95-100. PubMed ID: 2167752
    [Abstract] [Full Text] [Related]

  • 33. Effect of vanadate on the cellular accumulation of pp15, an apparent product of insulin receptor tyrosine kinase action.
    Bernier M, Laird DM, Lane MD.
    J Biol Chem; 1988 Sep 25; 263(27):13626-34. PubMed ID: 2458350
    [Abstract] [Full Text] [Related]

  • 34. Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes.
    Elberg G, He Z, Li J, Sekar N, Shechter Y.
    Diabetes; 1997 Nov 25; 46(11):1684-90. PubMed ID: 9356013
    [Abstract] [Full Text] [Related]

  • 35. Phosphorylation of insulin-like growth factor I receptor by insulin receptor tyrosine kinase in intact cultured skeletal muscle cells.
    Beguinot F, Smith RJ, Kahn CR, Maron R, Moses AC, White MF.
    Biochemistry; 1988 May 03; 27(9):3222-8. PubMed ID: 2839227
    [Abstract] [Full Text] [Related]

  • 36. Possible direct linkage of insulin-like growth factor-II receptor with guanine nucleotide-binding proteins.
    Nishimoto I, Murayama Y, Katada T, Ui M, Ogata E.
    J Biol Chem; 1989 Aug 25; 264(24):14029-38. PubMed ID: 2547780
    [Abstract] [Full Text] [Related]

  • 37. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
    Blondel O, Simon J, Chevalier B, Portha B.
    Am J Physiol; 1990 Mar 25; 258(3 Pt 1):E459-67. PubMed ID: 2180315
    [Abstract] [Full Text] [Related]

  • 38. Effect of inhibitors and activators of tyrosine kinase on insulin imprinting in Tetrahymena.
    Kovács P, Csaba G.
    Cell Biochem Funct; 1992 Dec 25; 10(4):267-71. PubMed ID: 1473267
    [Abstract] [Full Text] [Related]

  • 39. Interaction of insulin-like growth factor II with rat chondrocytes: receptor binding, internalization, and degradation.
    Sessions CM, Emler CA, Schalch DS.
    Endocrinology; 1987 May 25; 120(5):2108-16. PubMed ID: 2436896
    [Abstract] [Full Text] [Related]

  • 40. Specificity of tyrosine protein kinases of the structurally related receptors for insulin and insulin-like growth factor I: Tyr-containing synthetic polymers as specific inhibitors or substrates.
    Sahal D, Ramachandran J, Fujita-Yamaguchi Y.
    Arch Biochem Biophys; 1988 Jan 25; 260(1):416-26. PubMed ID: 2893587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.